ACM Research Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ACM Research in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ACM Research stock.
View analyst ratings for ACM Research or view top-rated stocks.

Wall Street analysts have given ACM Research a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ACM Research wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

ACM Research is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for ACM Research.

ACM Research, Inc. (NASDAQ:ACMR) posted its earnings results on Thursday, May, 6th. The specialty retailer reported $0.35 EPS for the quarter, beating the consensus estimate of $0.08 by $0.27. The specialty retailer had revenue of $43.73 million for the quarter, compared to analysts' expectations of $42.58 million. ACM Research had a trailing twelve-month return on equity of 14.60% and a net margin of 12.81%. ACM Research's revenue for the quarter was up 79.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.11 earnings per share.
View ACM Research's earnings history.

ACM Research's stock was trading at $25.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACMR stock has increased by 297.5% and is now trading at $101.75.
View which stocks have been most impacted by COVID-19.

ACM Research updated its FY 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $205 million-$230 million, compared to the consensus revenue estimate of $222.21 million.

7 equities research analysts have issued 1 year price targets for ACM Research's stock. Their forecasts range from $100.00 to $150.00. On average, they expect ACM Research's stock price to reach $126.00 in the next year. This suggests a possible upside of 23.8% from the stock's current price.
View analysts' price targets for ACM Research or view top-rated stocks among Wall Street analysts.

Some companies that are related to ACM Research include Brooks Automation (BRKS), IHI (IHICY), Sumitomo Heavy Industries (SOHVY), Desktop Metal (DM), Bodycote (BYPLF), Axcelis Technologies (ACLS), Veeco Instruments (VECO), Energy Recovery (ERII), iShares Agency Bond ETF (AGZ), Jaws Spitfire Acquisition (SPFR), Intevac (IVAC), Manitex International (MNTX), Amtech Systems (ASYS), Greystone Logistics (GLGI) and CVD Equipment (CVV).
View all of ACMR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ACM Research investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), QUALCOMM (QCOM), The Walt Disney (DIS), Square (SQ), Marvell Technology (MRVL), Taiwan Semiconductor Manufacturing (TSM) and AbbVie (ABBV).

(ACMR) raised $17 million in an initial public offering on Friday, November 3rd 2017. The company issued 2,000,000 shares at $7.50-$9.50 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group and The Benchmark Company were co-managers.

ACM Research trades on the NASDAQ under the ticker symbol "ACMR."

ACM Research's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.89%), Indus Capital Partners LLC (4.12%), Jericho Capital Asset Management L.P. (4.11%), Bamco Inc. NY (1.51%), Hillhouse Capital Advisors LTD. (1.29%) and Allianz Asset Management GmbH (1.25%). Company insiders that own ACM Research stock include Chenming Hu, David H Wang, Fuping Chen, Jian Wang, Lisa Feng, Mark Mckechnie, Sotheara Cheav, Tracy Liu and Yinan Xiang.
View institutional ownership trends for ACM Research.

ACMR stock was sold by a variety of institutional investors in the last quarter, including Indus Capital Partners LLC, Goldman Sachs Group Inc., Calamos Advisors LLC, Mitsubishi UFJ Trust & Banking Corp, Korea Investment CORP, Victory Capital Management Inc., FORA Capital LLC, and Price T Rowe Associates Inc. MD. Company insiders that have sold ACM Research company stock in the last year include Chenming Hu, David H Wang, Fuping Chen, Jian Wang, Lisa Feng, Mark Mckechnie, Sotheara Cheav, Tracy Liu, and Yinan Xiang.
View insider buying and selling activity for ACM Research or view top insider-selling stocks.

ACMR stock was acquired by a variety of institutional investors in the last quarter, including Jericho Capital Asset Management L.P., BlackRock Inc., Bamco Inc. NY, Allianz Asset Management GmbH, Millennium Management LLC, Panview Asian Equity Master Fund, NS Partners Ltd, and Credit Suisse AG.
View insider buying and selling activity for ACM Research or or view top insider-buying stocks.

Shares of ACMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACMR stock can currently be purchased for approximately $101.75.

ACM Research has a market capitalization of $1.76 billion and generates $156.62 million in revenue each year. The specialty retailer earns $18.78 million in net income (profit) each year or $1.12 on an earnings per share basis.

ACM Research employs 543 workers across the globe.

The official website for ACM Research is www.acmrcsh.com.

ACM Research is headquartered at 42307 OSGOOD ROAD SUITE I, FREMONT CA, 94539.

ACM Research's mailing address is 42307 OSGOOD ROAD SUITE I, FREMONT CA, 94539. The specialty retailer can be reached via phone at 510-445-3700 or via email at [email protected]